Literature DB >> 2045473

Lipolytic and ketogenic fluxes in human hyperthyroidism.

M Beylot1, C Martin, M Laville, J P Riou, R Cohen, R Mornex.   

Abstract

The effect of hyperthyroidism on lipolytic and ketogenic fluxes was determined by measuring simultaneously (stable isotope methodology) glycerol, nonesterified fatty acids (NEFA), and ketone body (KB) kinetics in euthyroid and hyperthyroid subjects. In the postabsorptive state hyperthyroid patients had normal concentrations of insulin and glucagon, but increased concentrations (P less than 0.01) and turnover rates (P less than 0.01) of glycerol, NEFA, and KB. The ratio of NEFA appearance rate to glycerol appearance rate was decreased in hyperthyroid subjects (2.34 +/- 0.23 vs. 3.15 +/- 0.22; P less than 0.05), indicating that intracellular cycling between triglycerides and fatty acids was increased. The percentage of NEFA flux used for KB production, calculated from NEFA disappearance rates and KB appearance rates, was increased in hyperthyroid patients (21.20 +/- 2.75% vs. 13.37 +/- 0.63%; P less than 0.05), suggesting a diversion during hyperthyroidism of hepatic fatty acid metabolism toward ketogenesis. However, when the plasma NEFA levels of control subjects were raised by the infusion of a triglyceride emulsion to levels comparable to those observed in hyperthyroid patients their percentage of NEFA flux used for ketogenesis rose to values slightly higher (26.30%) than those of hyperthyroid subjects. In conclusion, 1) hyperthyroidism results not only in increased lipolysis, but also in enhanced triglyceride-fatty acid cycling, which could contribute to the excessive energy expenditure; and 2) the increased KB production of hyperthyroid patients results more from an increase in NEFA availability than from a direct stimulation of hepatic ketogenesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2045473     DOI: 10.1210/jcem-73-1-42

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice.

Authors:  Lisen Johansson; Mats Rudling; Thomas S Scanlan; Thomas Lundåsen; Paul Webb; John Baxter; Bo Angelin; Paolo Parini
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

2.  Subclinical hypothyroidism and hyperthyroidism have opposite effects on hepatic very-low-density lipoprotein-triglyceride kinetics.

Authors:  Elisa Fabbrini; Faidon Magkos; Bruce W Patterson; Bettina Mittendorfer; Samuel Klein
Journal:  J Clin Endocrinol Metab       Date:  2012-01-11       Impact factor: 5.958

3.  A case of hyperglycemic hyperosmolar state associated with Graves' hyperthyroidism: a case report.

Authors:  Sung Won Moon; Jong Ryeal Hahm; Gyeong-Won Lee; Mi Yeon Kang; Jung Hwa Jung; Tae Sik Jung; Kang Wan Lee; Kyoung Ah Jung; Yong Jun Ahn; Sunjoo Kim; Me Ae Kim; Deok Ryong Kim; Soon Il Chung; Myoung Hee Park
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

4.  Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance.

Authors:  Miguel López; Luis Varela; María J Vázquez; Sergio Rodríguez-Cuenca; Carmen R González; Vidya R Velagapudi; Donald A Morgan; Erik Schoenmakers; Khristofor Agassandian; Ricardo Lage; Pablo Blanco Martínez de Morentin; Sulay Tovar; Rubén Nogueiras; David Carling; Christopher Lelliott; Rosalía Gallego; Matej Oresic; Krishna Chatterjee; Asish K Saha; Kamal Rahmouni; Carlos Diéguez; Antonio Vidal-Puig
Journal:  Nat Med       Date:  2010-08-29       Impact factor: 53.440

5.  Use of gas chromatography/isotope ratio-mass spectrometry to study triglyceride metabolism in humans.

Authors:  C Binnert; M Laville; C Pachiaudi; V Rigalleau; M Beylot
Journal:  Lipids       Date:  1995-09       Impact factor: 1.880

6.  Hypothalamic AMPK-ER Stress-JNK1 Axis Mediates the Central Actions of Thyroid Hormones on Energy Balance.

Authors:  Noelia Martínez-Sánchez; Patricia Seoane-Collazo; Cristina Contreras; Luis Varela; Joan Villarroya; Eva Rial-Pensado; Xabier Buqué; Igor Aurrekoetxea; Teresa C Delgado; Rafael Vázquez-Martínez; Ismael González-García; Juan Roa; Andrew J Whittle; Beatriz Gomez-Santos; Vidya Velagapudi; Y C Loraine Tung; Donald A Morgan; Peter J Voshol; Pablo B Martínez de Morentin; Tania López-González; Laura Liñares-Pose; Francisco Gonzalez; Krishna Chatterjee; Tomás Sobrino; Gema Medina-Gómez; Roger J Davis; Núria Casals; Matej Orešič; Anthony P Coll; Antonio Vidal-Puig; Jens Mittag; Manuel Tena-Sempere; María M Malagón; Carlos Diéguez; María Luz Martínez-Chantar; Patricia Aspichueta; Kamal Rahmouni; Rubén Nogueiras; Guadalupe Sabio; Francesc Villarroya; Miguel López
Journal:  Cell Metab       Date:  2017-07-05       Impact factor: 27.287

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.